Search research articles
Contact Us
Filters
Showing results (211-220 of 247) with videos related to
Page
of 25
Sort By:
Plos One
|
April 9, 2024
Mutations in the F protein of the live-attenuated respiratory syncytial virus vaccine candidate ΔNS2/Δ1313/I1314L increase the stability of infectivity and content of prefusion F protein
Judith Alamares-Sapuay, Michael Kishko, Charles Lai, et al.
Journal of Virology
|
July 11, 2008
Human parainfluenza virus type 1 C proteins are nonessential proteins that inhibit the host interferon and apoptotic responses and are required for efficient replication in nonhuman primates
Emmalene J Bartlett, Ann-Marie Cruz, Janice Esker, et al.
Journal of Virology
|
July 10, 2015
Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Prefusion F Protein Expressed by a Vaccine Candidate
Bo Liang, Sonja Surman, Emerito Amaro-Carambot, et al.
Journal of Virology
|
June 15, 2004
The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness
Mario H Skiadopoulos, Stéphane Biacchesi, Ursula J Buchholz, et al.
Journal of Virology
|
February 5, 2010
Interleukin 18 coexpression during respiratory syncytial virus infection results in enhanced disease mediated by natural killer cells
James A Harker, Alexandra Godlee, Jennifer L Wahlsten, et al.
The Journal of Infectious Diseases
|
March 5, 2005
Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants
Ruth A Karron, Peter F Wright, Robert B Belshe, et al.
Journal of Virology
|
May 18, 2018
Differential Responses by Human Respiratory Epithelial Cell Lines to Respiratory Syncytial Virus Reflect Distinct Patterns of Infection Control
Philippa Hillyer, Rachel Shepard, Megan Uehling, et al.
Plos Biology
|
July 22, 2009
CFTR delivery to 25% of surface epithelial cells restores normal rates of mucus transport to human cystic fibrosis airway epithelium
Liqun Zhang, Brian Button, Sherif E Gabriel, et al.
Molecular & Cellular Proteomics : MCP
|
February 11, 2012
The human respiratory syncytial virus nonstructural protein 1 regulates type I and type II interferon pathways
Marcus L Hastie, Madeleine J Headlam, Nirav B Patel, et al.
Open Forum Infectious Diseases
|
November 29, 2024
Infectivity and Immunogenicity of Live-Attenuated Respiratory Syncytial Virus Vaccines in Human Immunodeficiency Virus-Exposed Uninfected Children
Matthew S Kelly, Coleen K Cunningham, Elizabeth J McFarland, et al.
Page
of 25
Search research articles
Search
Showing results (211-220 of 247) with videos related to
Sort By:
Page
of 25
Plos One
|
April 9, 2024
Mutations in the F protein of the live-attenuated respiratory syncytial virus vaccine candidate ΔNS2/Δ1313/I1314L increase the stability of infectivity and content of prefusion F protein
Judith Alamares-Sapuay, Michael Kishko, Charles Lai, et al.
Journal of Virology
|
July 11, 2008
Human parainfluenza virus type 1 C proteins are nonessential proteins that inhibit the host interferon and apoptotic responses and are required for efficient replication in nonhuman primates
Emmalene J Bartlett, Ann-Marie Cruz, Janice Esker, et al.
Journal of Virology
|
July 10, 2015
Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Prefusion F Protein Expressed by a Vaccine Candidate
Bo Liang, Sonja Surman, Emerito Amaro-Carambot, et al.
Journal of Virology
|
June 15, 2004
The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness
Mario H Skiadopoulos, Stéphane Biacchesi, Ursula J Buchholz, et al.
Journal of Virology
|
February 5, 2010
Interleukin 18 coexpression during respiratory syncytial virus infection results in enhanced disease mediated by natural killer cells
James A Harker, Alexandra Godlee, Jennifer L Wahlsten, et al.
The Journal of Infectious Diseases
|
March 5, 2005
Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants
Ruth A Karron, Peter F Wright, Robert B Belshe, et al.
Journal of Virology
|
May 18, 2018
Differential Responses by Human Respiratory Epithelial Cell Lines to Respiratory Syncytial Virus Reflect Distinct Patterns of Infection Control
Philippa Hillyer, Rachel Shepard, Megan Uehling, et al.
Plos Biology
|
July 22, 2009
CFTR delivery to 25% of surface epithelial cells restores normal rates of mucus transport to human cystic fibrosis airway epithelium
Liqun Zhang, Brian Button, Sherif E Gabriel, et al.
Molecular & Cellular Proteomics : MCP
|
February 11, 2012
The human respiratory syncytial virus nonstructural protein 1 regulates type I and type II interferon pathways
Marcus L Hastie, Madeleine J Headlam, Nirav B Patel, et al.
Open Forum Infectious Diseases
|
November 29, 2024
Infectivity and Immunogenicity of Live-Attenuated Respiratory Syncytial Virus Vaccines in Human Immunodeficiency Virus-Exposed Uninfected Children
Matthew S Kelly, Coleen K Cunningham, Elizabeth J McFarland, et al.
Page
of 25